Philip A. W. Dean
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Philip A. W. Dean has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- G. Michael Bancroft
University of Western Ontario
2 shared publications - Grant S. Henderson
Department of Earth Sciences, University of Toronto 2 , Toronto, Ontario M5S 3B1, Canada
2 shared publications - H. Wayne Nesbitt
University of Western Ontario
2 shared publications - Hilary A. Jenkins
Department of Chemistry & Chemical Biology, McMaster University, Hamilton, Canada
2 shared publications - Jagadese J. Vittal
Department of Chemistry National University of Singapore 3 Science Drive 3 Singapore 117543 Singapore
2 shared publications - James M. Hook
University of New South Wales
2 shared publications
Latest Publications
- Open Access
- 1 December 2023
- Published by AIP Publishing in AIP Advances
- Vol. 13 (12)
New assignments of Raman spectra of tetrahedra and the effects of electronegativity. I. P4O10 and Si-containing molecules
Our new density functional theory calculations by Gaussian reproduce the bond lengths and Raman spectra of a number of model tetrahedral Si and P compounds [the ten compounds in the SiHxD4−x and SiFxCl4−x (x = 0–4) series, and the tetramer P4O10]. The number of symmetric A1 peaks is determined by group theory, and the center of mass is especially important for the assignment of the three A1 peaks for P4O10 to the two P–O stretches and the O–P–O bend. Additional Gaussian calculations on isolated C3v PO4 tetrahedra, using the P–O bond lengths and O–P–O bond angles from the P4O10 optimization, also reproduce the three peak P4O10 Raman spectra and provide an important guide to the assignment of the two low energy peaks at ∼500 and ∼700 cm−1 to the P–BO (BO = P–O–P) stretch and BO–P–BO bend, respectively, in contrast to all earlier assignments. In the SiFxCl4−x series, there is a regular increase in the Si–F A1 frequency and a decrease in the Si–Cl A1 frequency across the series. Similar trends are seen in the SiClx(CH3)4−x series, and these trends are due to changes in the electron densities in the tetrahedron when an electronegative F or Cl is replaced by a less electronegative Cl or CH3, as measured by previous Si 2p, F 1s, Cl 2p, and C 1s x-ray photoelectron spectroscopy. These considerations serve as a guide for the interpretation of the Raman spectra of silicate glasses in Paper II [Bancroft et al., AIP Adv. 13, 125216 (2023)].
- 1 December 2023
- Published by AIP Publishing in AIP Advances
- Vol. 13 (12)
Open AccessNew assignments of Raman spectra of tetrahedra and the effects of electronegativity. I. P4O10 and Si-containing molecules
Our new density functional theory calculations by Gaussian reproduce the bond lengths and Raman spectra of a number of model tetrahedral Si and P compounds [the ten compounds in the SiHxD4−x and SiFxCl4−x (x = 0–4) series, and the tetramer P4O10]. The number of symmetric A1 peaks is determined by group theory, and the center of mass is especially important for the assignment of the three A1 peaks for P4O10 to the two P–O stretches and the O–P–O bend. Additional Gaussian calculations on isolated C3v PO4 tetrahedra, using the P–O bond lengths and O–P–O bond angles from the P4O10 optimization, also reproduce the three peak P4O10 Raman spectra and provide an important guide to the assignment of the two low energy peaks at ∼500 and ∼700 cm−1 to the P–BO (BO = P–O–P) stretch and BO–P–BO bend, respectively, in contrast to all earlier assignments. In the SiFxCl4−x series, there is a regular increase in the Si–F A1 frequency and a decrease in the Si–Cl A1 frequency across the series. Similar trends are seen in the SiClx(CH3)4−x series, and these trends are due to changes in the electron densities in the tetrahedron when an electronegative F or Cl is replaced by a less electronegative Cl or CH3, as measured by previous Si 2p, F 1s, Cl 2p, and C 1s x-ray photoelectron spectroscopy. These considerations serve as a guide for the interpretation of the Raman spectra of silicate glasses in Paper II [Bancroft et al., AIP Adv. 13, 125216 (2023)].
- Open Access
- 1 December 2023
- Published by AIP Publishing in AIP Advances
- Vol. 13 (12)
New assignments of Raman spectra of tetrahedra and the effects of electronegativity. II. Silicate glasses
Our density functional theory calculations (by GAUSSIAN) on the Si4O104− moiety and Na4Si4O10 molecule reproduce the experimental Raman frequencies and relative intensities for the three A1 modes in the experimental Raman spectra of Na2Si2O5 and BaSi2O5 crystals and glasses. Taking the center of mass into consideration, accompanied by visualization using GaussView, these calculations provide a firm assignment of these three peaks: the 1060 cm−1 peak to the Si-NBO stretch (NBO = Si–O or Si–O–Na), the ∼600 cm−1 peak to the Si-BO stretch (BO = Si–O–Si), and the ∼500 cm−1 peak to the Si-BO-Si bend. Our GAUSSIAN calculations on modified “non-equilibrium” SiO44− tetrahedra, constrained to have the same Si–O bond lengths and O–Si–O bond angles as in the Si4O104− moiety, confirm the above-mentioned assignment and show reasonable agreement with the experimental Raman frequencies and relative intensities. We then examine the regular trends in the Si-NBO and Si-BO stretch frequencies for all Qn (n = 0–4) species in silicate glasses and crystals. The large systematic change in the differences between these frequencies (Δ1) is explained by electronic changes within the SiO4 tetrahedron. For example, the larger Δ1 for the Q3 tetrahedra than the Q2 tetrahedra is due to the changes in Si, BO, and NBO electron densities on the tetrahedral Si and O atoms, as measured by Si 2p and O 1s x-ray photoelectron spectra. This trend strongly suggests that the Si-BO stretch frequency for the Q4 species in v-SiO2 should be ∼500 cm−1, close to the A1 breathing mode frequency of 495 cm−1 for four membered rings previously assigned.
- 1 December 2023
- Published by AIP Publishing in AIP Advances
- Vol. 13 (12)
Open AccessNew assignments of Raman spectra of tetrahedra and the effects of electronegativity. II. Silicate glasses
Our density functional theory calculations (by GAUSSIAN) on the Si4O104− moiety and Na4Si4O10 molecule reproduce the experimental Raman frequencies and relative intensities for the three A1 modes in the experimental Raman spectra of Na2Si2O5 and BaSi2O5 crystals and glasses. Taking the center of mass into consideration, accompanied by visualization using GaussView, these calculations provide a firm assignment of these three peaks: the 1060 cm−1 peak to the Si-NBO stretch (NBO = Si–O or Si–O–Na), the ∼600 cm−1 peak to the Si-BO stretch (BO = Si–O–Si), and the ∼500 cm−1 peak to the Si-BO-Si bend. Our GAUSSIAN calculations on modified “non-equilibrium” SiO44− tetrahedra, constrained to have the same Si–O bond lengths and O–Si–O bond angles as in the Si4O104− moiety, confirm the above-mentioned assignment and show reasonable agreement with the experimental Raman frequencies and relative intensities. We then examine the regular trends in the Si-NBO and Si-BO stretch frequencies for all Qn (n = 0–4) species in silicate glasses and crystals. The large systematic change in the differences between these frequencies (Δ1) is explained by electronic changes within the SiO4 tetrahedron. For example, the larger Δ1 for the Q3 tetrahedra than the Q2 tetrahedra is due to the changes in Si, BO, and NBO electron densities on the tetrahedral Si and O atoms, as measured by Si 2p and O 1s x-ray photoelectron spectra. This trend strongly suggests that the Si-BO stretch frequency for the Q4 species in v-SiO2 should be ∼500 cm−1, close to the A1 breathing mode frequency of 495 cm−1 for four membered rings previously assigned.
- 1 February 2005
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 83 (2) , 174-184
A synthetic, structural, and 113Cd NMR study of cadmium complexes of 1,3-thiazolidine-2-thionate, including the structures of Cd(C3H4NS2)2, (Cd(C3H4NS2)2(C5H5N)3·C5H5N, and (Ph4P)2[I2Cd(µ-C3H4NS2)2CdI2]
The crystallization of cadmium bis(1,3-thiazolidine-2-thionate), Cd(C3H4NS2)2 (1), is reported. Freshly prepared 1 reacts with Ph4P+X in a 1:2 ratio to give (Ph4P)2[Cd2(C3H4NS2)2X4] (X = I (4) or Br (5)). Crystallization of 1 from pyridine produces a solvate 7, which loses pyridine readily. X-ray analyses show that 1 has a polymeric sheet structure in which the C3H4NS2 ligands act as bidentate bridges through N and the exocyclic S and the Cd has a CdN2S2 kernel; 5 is isomorphous with 4, which contains a dimeric anion again with bridging through the N and exocyclic S of the heterocyclic ligands; and 7 is Cd(C3H4NS2)2(C5H5N)3·C5H5N, containing trigonal bipyramidal Cd(C3H4NS2)2(C5H5N)3 molecules, in which the C3H4NS2 ligands, both of which are monodentate and in equatorial positions, occur as a unique combination of S- and N-bound. Cadmium-113 NMR data for 1 in pyridine solution and solid-state CP-MAS 113Cd data for 1, 7, bis(pyridinium-4-thiolate)cadmium, and tetrakis(pyridinium-2-thiolate)cadmium nitrate are reported and discussed. The compound 1 has chemical and NMR spectroscopic properties that make it a useful standard for solid-state CP-MAS 113Cd NMR spectroscopy. Key words: cadmium, 1,3-thiazolidine-2-thionate, X-ray analysis, solid-state 113Cd NMR, 113Cd NMR standard compound.
- 1 February 2005
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 83 (2) , 174-184
A synthetic, structural, and 113Cd NMR study of cadmium complexes of 1,3-thiazolidine-2-thionate, including the structures of Cd(C3H4NS2)2, (Cd(C3H4NS2)2(C5H5N)3·C5H5N, and (Ph4P)2[I2Cd(µ-C3H4NS2)2CdI2]
The crystallization of cadmium bis(1,3-thiazolidine-2-thionate), Cd(C3H4NS2)2 (1), is reported. Freshly prepared 1 reacts with Ph4P+X in a 1:2 ratio to give (Ph4P)2[Cd2(C3H4NS2)2X4] (X = I (4) or Br (5)). Crystallization of 1 from pyridine produces a solvate 7, which loses pyridine readily. X-ray analyses show that 1 has a polymeric sheet structure in which the C3H4NS2 ligands act as bidentate bridges through N and the exocyclic S and the Cd has a CdN2S2 kernel; 5 is isomorphous with 4, which contains a dimeric anion again with bridging through the N and exocyclic S of the heterocyclic ligands; and 7 is Cd(C3H4NS2)2(C5H5N)3·C5H5N, containing trigonal bipyramidal Cd(C3H4NS2)2(C5H5N)3 molecules, in which the C3H4NS2 ligands, both of which are monodentate and in equatorial positions, occur as a unique combination of S- and N-bound. Cadmium-113 NMR data for 1 in pyridine solution and solid-state CP-MAS 113Cd data for 1, 7, bis(pyridinium-4-thiolate)cadmium, and tetrakis(pyridinium-2-thiolate)cadmium nitrate are reported and discussed. The compound 1 has chemical and NMR spectroscopic properties that make it a useful standard for solid-state CP-MAS 113Cd NMR spectroscopy. Key words: cadmium, 1,3-thiazolidine-2-thionate, X-ray analysis, solid-state 113Cd NMR, 113Cd NMR standard compound.
- 1 September 2001
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 79 (9) , 1330-1337
Cadmium complexes of thiones. Part II.1 A synthetic, solution, and solid-state MAS 111/113Cd NMR study of cadmium complexes of 1,3-thiazolidine-2-thione, and the structures of [tetrakis(1,3-thiazolidine-2-thione)cadmium] trifluoromethanesulfonate ([Cd(C3H5NS2)4](CF3SO3)2) and [tetrakis(1,3-thiazolidine-2-thione)cadmium][tetrakis(nitrato-O,O')cadmate] ([Cd(C3H5NS2)4][Cd(O2NO)4])
Treatment of Cd(O3SCF3)2 with the stoichiometric quantity of 1,3-thiazolidine-2-thione (tztH) allows isolation of [Cd(tztH)4](O3SCF3)2 (1). When tztH:Cd [ ] 2 the reaction of Cd(NO3)2·4H2O with tztH leads to [Cd(tztH)4][Cd(O2NO)4] (2). The structures of both 1 and 2 have been determined by single crystal X-ray analysis. Colourless crystals of 1 are orthorhombic, space group Fdd2, with eight molecules per unit cell (Z = 8) of dimensions a = 20.139(3), b = 23.332(5), c = 14.214(3) Å. Those of 2 are tetragonal, space group I [ ], with four molecules per unit cell (Z = 4) of dimensions a = 13.8853(11), c = 8.077(2) Å. The discrete homoleptic cation [Cd(tztH)4]2+ is characterized for the first time in 1 and 2. The cations are of point group symmetry C2 and S4 in 1 and 2, respectively. In both cases the ligands are S-bound, and the CdS4 kernel is a squashed tetrahedron. In 2, the eight-coordinate anion [Cd(O2NO)4]2- is characterized for the second time. 113Cd CP MAS NMR data are reported for solid 1 and 2, and also for solids produced by fusing Cd(NO3)2·4H2O with different molar ratios amounts of tztH, and by fusing Cd(O3SCF3)2 with six mol equivalents of tztH. In the Cd(NO3)2·4H2O:tztH mixtures, species identified include unreacted cadmium salt 2 ([Cd(tztH)4](NO3)2) and possibly Cd(tztH)3(NO3)2. [Cd(tztH)4](NO3)2 becomes the major species only when a significant excess of tztH is used. In the mixtures with tztH:Cd > 4, neither Cd(NO3)2·4H2O nor Cd(O3SCF3)2 form complexes containing more than four tztH ligands. Reduced-temperature 111Cd NMR data are reported for Cd(ClO4)2·6H2O:tztH mixtures in MeOH. Species identified are Cd(tztH)w2+(solv) (w = 0–3).Key words: 1,3-thiazolidine-2-thione, cadmium complexes, X-ray analysis, 113Cd CP MAS NMR, solution 111Cd NMR, tetrakis(1,3-thiazolidine-2-thione)cadmium(2+) cation, tetrakis(nitrato-O,O')cadmate(2–) anion.
- 1 September 2001
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 79 (9) , 1330-1337
Cadmium complexes of thiones. Part II.1 A synthetic, solution, and solid-state MAS 111/113Cd NMR study of cadmium complexes of 1,3-thiazolidine-2-thione, and the structures of [tetrakis(1,3-thiazolidine-2-thione)cadmium] trifluoromethanesulfonate ([Cd(C3H5NS2)4](CF3SO3)2) and [tetrakis(1,3-thiazolidine-2-thione)cadmium][tetrakis(nitrato-O,O')cadmate] ([Cd(C3H5NS2)4][Cd(O2NO)4])
Treatment of Cd(O3SCF3)2 with the stoichiometric quantity of 1,3-thiazolidine-2-thione (tztH) allows isolation of [Cd(tztH)4](O3SCF3)2 (1). When tztH:Cd [ ] 2 the reaction of Cd(NO3)2·4H2O with tztH leads to [Cd(tztH)4][Cd(O2NO)4] (2). The structures of both 1 and 2 have been determined by single crystal X-ray analysis. Colourless crystals of 1 are orthorhombic, space group Fdd2, with eight molecules per unit cell (Z = 8) of dimensions a = 20.139(3), b = 23.332(5), c = 14.214(3) Å. Those of 2 are tetragonal, space group I [ ], with four molecules per unit cell (Z = 4) of dimensions a = 13.8853(11), c = 8.077(2) Å. The discrete homoleptic cation [Cd(tztH)4]2+ is characterized for the first time in 1 and 2. The cations are of point group symmetry C2 and S4 in 1 and 2, respectively. In both cases the ligands are S-bound, and the CdS4 kernel is a squashed tetrahedron. In 2, the eight-coordinate anion [Cd(O2NO)4]2- is characterized for the second time. 113Cd CP MAS NMR data are reported for solid 1 and 2, and also for solids produced by fusing Cd(NO3)2·4H2O with different molar ratios amounts of tztH, and by fusing Cd(O3SCF3)2 with six mol equivalents of tztH. In the Cd(NO3)2·4H2O:tztH mixtures, species identified include unreacted cadmium salt 2 ([Cd(tztH)4](NO3)2) and possibly Cd(tztH)3(NO3)2. [Cd(tztH)4](NO3)2 becomes the major species only when a significant excess of tztH is used. In the mixtures with tztH:Cd > 4, neither Cd(NO3)2·4H2O nor Cd(O3SCF3)2 form complexes containing more than four tztH ligands. Reduced-temperature 111Cd NMR data are reported for Cd(ClO4)2·6H2O:tztH mixtures in MeOH. Species identified are Cd(tztH)w2+(solv) (w = 0–3).Key words: 1,3-thiazolidine-2-thione, cadmium complexes, X-ray analysis, 113Cd CP MAS NMR, solution 111Cd NMR, tetrakis(1,3-thiazolidine-2-thione)cadmium(2+) cation, tetrakis(nitrato-O,O')cadmate(2–) anion.
- 1 November 1996
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 74 (11) , 2095-2105
Pyridine-2-selenolate and -2-tellurolate as ligands: a multinuclear (77Se, 119Sn, 125Te) magnetic resonance study of some tin(IV) complexes, and X-ray structural analyses of Sn(SPh)2(2-Se-C5H4N-N,Se)2 and Sn(SPh)1.85(2-Se-C5H4N)2.15
Reactions between Sn(E′Ph)n (E′ = S or Se; n = 2 or 4) and the bis(pyridine) dichalcogenides 2,2′-(C5H4NE)2 (E = Se or Te), abbreviated py2E2, have been studied using multinuclear (77Se, 119Sn, 125Te) magnetic resonance. In this way the occurrence of the pyridine-2-chalcogenate complexes Sn(E′Ph)4−x(Epy)x (E′ = S or Se; E = Se, x = 1–4; E = Te, x = 1 or 2) has been demonstrated. The pattern of 119Sn NMR chemical shifts for Sn(E′Ph)4−x(Sepy)x (E′ = S or Se, x = 0–4) is consistent with bidentate bonding for the pySe− ligand when x = 1 and 2. The pyTe− ligand is probably bidentate also in all four complexes containing this ligand. As part of the NMR analysis, 77Se and (or) 125Te NMR data were obtained for py2Te2 and for the new mixed dichalcogenides PhE′ER (E′ = S, Se, or Te; E ≠ E′ = Se or Te; R = 2-py or Ph), which were produced in the systems Ph2E′2:R2E2. The complex Sn(SPh)2(Sepy)2 (1) was isolated pure and its structure determined by the single crystal X-diffraction technique. The compound crystallizes in the monoclinic space group P21/n, with unit cell dimensions a = 9.7929(9) Å, b = 22.340(2) Å, c = 11.368(1) Å, β = 108.803(7) °, V = 2354.3(4) Å3, dcalc = 1.837 g cm−3 and Z = 4. Refinement by full-matrix least squares on F2 gave agreement factors R1 = 0.0425 and wR2 = 0.0882 for 2823 independent reflections with F0 ≥ 4σ(F0) and 258 variables. The structure confirms that the PySe− ligand behaves in a chelating manner. The molecule Sn(SPh)2(2-Se-C5H4N-N,Se)2 has a distorted octahedral structure with the PhS− ligands in cis positions and the two Se donor atoms in trans positions. The Sn—Se, Sn—S, and Sn—N distances are 2.6291(8) and 2.6358(8) Å, 2.475(2) and 2.464(2) Å, and 2.325(5) and 2.333(5) Å. The bite angles N-Sn-Se of the chelating ligands are 65.9(1)° and 65.8(1)°. En route to 1, the yellow crystalline compound Sn(SPh)1 85(2-Se-C5H4N)2 15 (2) was isolated. This was shown by 119Sn NMR spectroscopy to contain both Sn(2-Se-C5H4N)2(SPh)2 and Sn(2-Se-C5H4N)3(SPh). The crystal and molecular structure of 2 was determined by single crystal X-ray diffraction techniques. Crystal data: monoclinic, space group P21/n, a = 9.795(2) Å, b = 22.355(4) Å, c = 11.362(2) Å, β = 108.87(3)°, V = 2354.2(8) Å3, dcalc = 1.837 g cm−3, dobs = 1.87(5) g cm−3Z = 4, R1 = 0.0306, wR2 = 0.0651 for 2756 data (F0 ≥ 4σ(F0)) and 258 parameters. Crystallographic evidence for the presence of co-crystallized Sn(2-Se-C5H4N)3(SPh) occurs only in a minor lengthening of one of the two Sn—S bonds, Sn—S(1) (compared with expectation for 1), and an excess of electron density at S(1) when the data are modelled as Sn(2-Se-C5H4N)2(SPh)2. These effects are attributed to a crystallographic disorder of SPh and η1-{2-Se-C5H4N} at the S(1)Ph site, involving isostructural Sn(η2-{2-Se-C5H4N})2({η1-{2-Se-C5H4N})(SPh) and Sn(η2-{2-Se-C5H4N})2(SPh)2. Key words: pyridine-2-selenolate, pyridine-2-tellurolate, tin complexes.- 1 November 1996
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 74 (11) , 2095-2105
Pyridine-2-selenolate and -2-tellurolate as ligands: a multinuclear (77Se, 119Sn, 125Te) magnetic resonance study of some tin(IV) complexes, and X-ray structural analyses of Sn(SPh)2(2-Se-C5H4N-N,Se)2 and Sn(SPh)1.85(2-Se-C5H4N)2.15
Reactions between Sn(E′Ph)n (E′ = S or Se; n = 2 or 4) and the bis(pyridine) dichalcogenides 2,2′-(C5H4NE)2 (E = Se or Te), abbreviated py2E2, have been studied using multinuclear (77Se, 119Sn, 125Te) magnetic resonance. In this way the occurrence of the pyridine-2-chalcogenate complexes Sn(E′Ph)4−x(Epy)x (E′ = S or Se; E = Se, x = 1–4; E = Te, x = 1 or 2) has been demonstrated. The pattern of 119Sn NMR chemical shifts for Sn(E′Ph)4−x(Sepy)x (E′ = S or Se, x = 0–4) is consistent with bidentate bonding for the pySe− ligand when x = 1 and 2. The pyTe− ligand is probably bidentate also in all four complexes containing this ligand. As part of the NMR analysis, 77Se and (or) 125Te NMR data were obtained for py2Te2 and for the new mixed dichalcogenides PhE′ER (E′ = S, Se, or Te; E ≠ E′ = Se or Te; R = 2-py or Ph), which were produced in the systems Ph2E′2:R2E2. The complex Sn(SPh)2(Sepy)2 (1) was isolated pure and its structure determined by the single crystal X-diffraction technique. The compound crystallizes in the monoclinic space group P21/n, with unit cell dimensions a = 9.7929(9) Å, b = 22.340(2) Å, c = 11.368(1) Å, β = 108.803(7) °, V = 2354.3(4) Å3, dcalc = 1.837 g cm−3 and Z = 4. Refinement by full-matrix least squares on F2 gave agreement factors R1 = 0.0425 and wR2 = 0.0882 for 2823 independent reflections with F0 ≥ 4σ(F0) and 258 variables. The structure confirms that the PySe− ligand behaves in a chelating manner. The molecule Sn(SPh)2(2-Se-C5H4N-N,Se)2 has a distorted octahedral structure with the PhS− ligands in cis positions and the two Se donor atoms in trans positions. The Sn—Se, Sn—S, and Sn—N distances are 2.6291(8) and 2.6358(8) Å, 2.475(2) and 2.464(2) Å, and 2.325(5) and 2.333(5) Å. The bite angles N-Sn-Se of the chelating ligands are 65.9(1)° and 65.8(1)°. En route to 1, the yellow crystalline compound Sn(SPh)1 85(2-Se-C5H4N)2 15 (2) was isolated. This was shown by 119Sn NMR spectroscopy to contain both Sn(2-Se-C5H4N)2(SPh)2 and Sn(2-Se-C5H4N)3(SPh). The crystal and molecular structure of 2 was determined by single crystal X-ray diffraction techniques. Crystal data: monoclinic, space group P21/n, a = 9.795(2) Å, b = 22.355(4) Å, c = 11.362(2) Å, β = 108.87(3)°, V = 2354.2(8) Å3, dcalc = 1.837 g cm−3, dobs = 1.87(5) g cm−3Z = 4, R1 = 0.0306, wR2 = 0.0651 for 2756 data (F0 ≥ 4σ(F0)) and 258 parameters. Crystallographic evidence for the presence of co-crystallized Sn(2-Se-C5H4N)3(SPh) occurs only in a minor lengthening of one of the two Sn—S bonds, Sn—S(1) (compared with expectation for 1), and an excess of electron density at S(1) when the data are modelled as Sn(2-Se-C5H4N)2(SPh)2. These effects are attributed to a crystallographic disorder of SPh and η1-{2-Se-C5H4N} at the S(1)Ph site, involving isostructural Sn(η2-{2-Se-C5H4N})2({η1-{2-Se-C5H4N})(SPh) and Sn(η2-{2-Se-C5H4N})2(SPh)2. Key words: pyridine-2-selenolate, pyridine-2-tellurolate, tin complexes.- Open Access
- 1 June 1990
- Published by Wolters Kluwer Health in Hepatology
- Vol. 11 (6) , 1003-1009
Prostanoids and Leukotrienes in Experimental Feline Cholecystitis
Current information suggests that arachidonic acid metabolites are involved in the development of cholecystitis. The purpose of this study was to evalute eicosanoid formation during the development of experimental cholecystitis in cats. Lysophosphatidylcholine is found in the gallbladders of patients with cholecystitis and is known to be a cytolytic, membrane damaging substance. Anesthetized cats underwent gallbladder perfusion with and without 1.5 mmol/L lysophosphatidylcholine. Additional experiments were performed when calcium ionophore was added to the perfusates and experiments were performed when cats were treated with indomethacin and underwent perfusion with lysophosphatidylcholine. Changes in the gallbladder were determined by evaluating mucosal water transport as measured by determining the changes in concentration in a nonabsorbable marker, by protein secretion and by β–glucuronidase accumulation in gallbladder tissue as an index of inflammation. Eicosanoid formation was evaluated by measuring perfusate concentrations and gallbladder homogenate concentrations by radioimmunoassay of prostaglandin E, 6 keto prostaglandin F 1 α, leukotriene B4 and leukotriene C4. Lysophosphatidylcholine perfusion reversed the control patterns of absorption and produced water exsorption, produced an efflux of protein into the perfusate and increased β–glucuronidase activity. These changes were accompanied by increased production of prostaglandin E and 6 keto prostaglandin F1α in gallbladder perfusate and homogenate. The concentration of leukotrience C4 in gallbladder effusate was increased by lysophosphatidylcholine when compared with control values. Indomethacin inhibited the protein efflux, decreased β–glucuronidase levels and decreased prostaglandin E and 6 keto prostagladin F1 α formation when compared with values produced by lysophosphatidylcholine alone. Cyclooxygenase inhibition did not alter the secretion of water into the gallbladder or perfusate leukotriene C4 concentrations. Lysophosphatidylcholine alters gallbladder mucosal function, and these changes may be mediated by arachidonic acid metabolites.(HEPATOLOGY 1990;11:1003–1009.).
- 1 June 1990
- Published by Wolters Kluwer Health in Hepatology
- Vol. 11 (6) , 1003-1009
Open AccessProstanoids and Leukotrienes in Experimental Feline Cholecystitis
Current information suggests that arachidonic acid metabolites are involved in the development of cholecystitis. The purpose of this study was to evalute eicosanoid formation during the development of experimental cholecystitis in cats. Lysophosphatidylcholine is found in the gallbladders of patients with cholecystitis and is known to be a cytolytic, membrane damaging substance. Anesthetized cats underwent gallbladder perfusion with and without 1.5 mmol/L lysophosphatidylcholine. Additional experiments were performed when calcium ionophore was added to the perfusates and experiments were performed when cats were treated with indomethacin and underwent perfusion with lysophosphatidylcholine. Changes in the gallbladder were determined by evaluating mucosal water transport as measured by determining the changes in concentration in a nonabsorbable marker, by protein secretion and by β–glucuronidase accumulation in gallbladder tissue as an index of inflammation. Eicosanoid formation was evaluated by measuring perfusate concentrations and gallbladder homogenate concentrations by radioimmunoassay of prostaglandin E, 6 keto prostaglandin F 1 α, leukotriene B4 and leukotriene C4. Lysophosphatidylcholine perfusion reversed the control patterns of absorption and produced water exsorption, produced an efflux of protein into the perfusate and increased β–glucuronidase activity. These changes were accompanied by increased production of prostaglandin E and 6 keto prostaglandin F1α in gallbladder perfusate and homogenate. The concentration of leukotrience C4 in gallbladder effusate was increased by lysophosphatidylcholine when compared with control values. Indomethacin inhibited the protein efflux, decreased β–glucuronidase levels and decreased prostaglandin E and 6 keto prostagladin F1 α formation when compared with values produced by lysophosphatidylcholine alone. Cyclooxygenase inhibition did not alter the secretion of water into the gallbladder or perfusate leukotriene C4 concentrations. Lysophosphatidylcholine alters gallbladder mucosal function, and these changes may be mediated by arachidonic acid metabolites.(HEPATOLOGY 1990;11:1003–1009.).